Overview

Hematopoiesis (also haematopoiesis or haemopoiesis) is the continuous generation of the various types of blood cells required for oxygen delivery, immunity and hemostasis. In healthy adults the system replaces a large number of cells each day — on the order of 10^11 to 10^12 newly formed cells — to maintain steady levels in the circulation. The process is tightly regulated so that production matches physiologic demand.

Cells and compartments

The source of all mature blood elements is the hematopoietic stem cell (HSC), sometimes called a hemocytoblast. HSCs are long-lived, self-renewing cells that reside primarily in the central cavities of bones: the bone marrow. From HSCs arise intermediate progenitor populations that gradually lose developmental potential and commit to specific lineages. Researchers track this progression by measuring changes in gene expression and the appearance or loss of proteins on the cell surface, including well-known markers used in clinical and laboratory analysis.

Major developmental pathways

  • Erythropoiesis – formation of red blood cells that transport oxygen, stimulated by factors such as erythropoietin.
  • Myelopoiesis – production of granulocytes and monocytes involved in innate immunity; influenced by colony-stimulating factors.
  • Lymphopoiesis – generation of lymphocytes that mediate adaptive immune responses.
  • Megakaryopoiesis – development of platelet-producing megakaryocytes, regulated in part by thrombopoietin.

Developmental history and anatomy

Hematopoiesis begins in the embryo in extra-medullary sites such as the yolk sac and later the fetal liver and spleen, before becoming concentrated in the marrow of long bones and the axial skeleton after birth. The marrow microenvironment, or niche, supplies signals and physical contacts that help determine whether an HSC self-renews, differentiates or remains quiescent. Disruption of these signals alters blood production and can contribute to disease.

Clinical importance and applications

Understanding HSC biology has enabled life-saving treatments. Transplantation of bone marrow or mobilized stem cells is a standard therapy for many cancers, bone marrow failure syndromes and certain immune disorders, and HSCs are the basis for regenerative strategies. Drugs that mimic or block natural growth factors (for example granulocyte colony-stimulating factors) are used to boost specific lineages in clinical care and research. Advances in cell-sorting and transplantation techniques grew from decades of basic study of stem cell behavior.

Notable features and distinctions

Hematopoiesis illustrates general principles of stem cell biology: a rare, multipotent stem cell gives rise to many specialized progeny through progressive restriction of fate. The immune system depends on hematopoiesis for continual renewal and adaptation; disorders of the system affect both blood formation and host defense (immune system). Modern laboratory and clinical work often references HSC markers and lineage definitions to diagnose disease and guide therapy; for more technical background see sources on stem cell markers and marrow physiology (stem cells, mature blood cells, gene regulation).